CompaniesInnogen Pharmaceutical

Innogen Pharmaceutical

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

832

By Phase

PHASE1/PHASE2: 1PHASE2/PHASE3: 1PHASE2: 3

By Status

COMPLETED: 3UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00215566
NCT00547469
NCT02693093
Hover over trial bars to see details

Recent Trials

NCT02693093Lead Sponsor
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
PHASE1/PHASE2Completed
264 participants
Started: Feb 24, 2016 · Completed: Dec 30, 2021
NCT00547469Lead Sponsor
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
PHASE2/PHASE3Unknown
360 participants
Started: Oct 31, 2007
NCT00252993Lead Sponsor
12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting
PHASE2Terminated
30 participants
Started: Nov 30, 2005 · Completed: Mar 31, 2006
NCT00215566Lead Sponsor
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
PHASE2Completed
90 participants
Started: Sep 30, 2005
NCT00230581Lead Sponsor
8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
PHASE2Completed
88 participants
Started: Sep 30, 2005 · Completed: Aug 31, 2007